These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15745419)

  • 41. Role of CAGE, a novel cancer/testis antigen, in various cellular processes, including tumorigenesis, cytolytic T lymphocyte induction, and cell motility.
    Kim Y; Jeoung D
    J Microbiol Biotechnol; 2008 Mar; 18(3):600-10. PubMed ID: 18388483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a novel prostate cancer-associated tumor antigen.
    Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
    Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.
    Behrends U; Schneider I; Rössler S; Frauenknecht H; Golbeck A; Lechner B; Eigenstetter G; Zobywalski C; Müller-Weihrich S; Graubner U; Schmid I; Sackerer D; Späth M; Goetz C; Prantl F; Asmuss HP; Bise K; Mautner J
    Int J Cancer; 2003 Aug; 106(2):244-51. PubMed ID: 12800201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis.
    Hayashi E; Matsuzaki Y; Hasegawa G; Yaguchi T; Kurihara S; Fujita T; Kageshita T; Sano M; Kawakami Y
    Clin Cancer Res; 2007 Nov; 13(21):6267-74. PubMed ID: 17975137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serological analysis of human renal cell carcinoma.
    Devitt G; Meyer C; Wiedemann N; Eichmüller S; Kopp-Schneider A; Haferkamp A; Hautmann R; Zöller M
    Int J Cancer; 2006 May; 118(9):2210-9. PubMed ID: 16331622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitofilin and titin as target antigens in melanoma-associated retinopathy.
    Pföhler C; Preuss KD; Tilgen W; Stark A; Regitz E; Fadle N; Pfreundschuh M
    Int J Cancer; 2007 Feb; 120(4):788-95. PubMed ID: 17131336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SEREX analysis of gastric cancer antigens.
    Obata Y; Takahashi T; Sakamoto J; Tamaki H; Tominaga S; Hamajima N; Chen YT; Old LJ
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S37-42. PubMed ID: 10950146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploitation of the B cell repertoire for the identification of human tumor antigens.
    Pfreundschuh M
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S3-7. PubMed ID: 10950139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA).
    Lagarkova MA; Koroleva EP; Kuprash DV; Boitchenko VE; Kashkarova UA; Nedospasov SA; Shebzukhov YV
    Immunol Lett; 2003 Jan; 85(1):71-4. PubMed ID: 12505200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers.
    Shigematsu Y; Hanagiri T; Kuroda K; Baba T; Mizukami M; Ichiki Y; Yasuda M; Takenoyama M; Sugio K; Yasumoto K
    Cancer Sci; 2009 Jul; 100(7):1326-34. PubMed ID: 19432887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course.
    Mizukami M; Hanagiri T; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Yasuda M; Takenoyama M; Sugio K; Yasumoto K
    Cancer Sci; 2005 Dec; 96(12):882-8. PubMed ID: 16367908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens.
    Türeci O; Sahin U; Zwick C; Neumann F; Pfreundschuh M
    Hybridoma; 1999 Feb; 18(1):23-8. PubMed ID: 10211784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of prostate cancer antigens by automated high-throughput filter immunoscreening.
    Alsøe L; Stacy JE; Fosså A; Funderud S; Brekke OH; Gaudernack G
    J Immunol Methods; 2008 Jan; 330(1-2):12-23. PubMed ID: 18045611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the antibody repertoire of lymphoma patients.
    Huang S; Preuss KD; Xie X; Regitz E; Pfreundschuh M
    Cancer Immunol Immunother; 2002 Dec; 51(11-12):655-62. PubMed ID: 12439611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma.
    Diesinger I; Bauer C; Brass N; Schaefers HJ; Comtesse N; Sybrecht G; Meese E
    Int J Cancer; 2002 Dec; 102(4):372-8. PubMed ID: 12402307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of human colon cancer antigens recognized by autologous antibodies.
    Scanlan MJ; Chen YT; Williamson B; Gure AO; Stockert E; Gordan JD; Türeci O; Sahin U; Pfreundschuh M; Old LJ
    Int J Cancer; 1998 May; 76(5):652-8. PubMed ID: 9610721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library.
    Somers VA; Brandwijk RJ; Joosten B; Moerkerk PT; Arends JW; Menheere P; Pieterse WO; Claessen A; Scheper RJ; Hoogenboom HR; Hufton SE
    J Immunol; 2002 Sep; 169(5):2772-80. PubMed ID: 12193752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas.
    Schmits R; Cochlovius B; Treitz G; Regitz E; Ketter R; Preuss KD; Romeike BF; Pfreundschuh M
    Int J Cancer; 2002 Mar; 98(1):73-7. PubMed ID: 11857388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries.
    Sioud M; Hansen MH
    Eur J Immunol; 2001 Mar; 31(3):716-25. PubMed ID: 11241275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping the high throughput SEREX technology screening for novel tumor antigens.
    Zhou S; Yi T; Zhang B; Huang F; Huang H; Tang J; Zhao X
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):202-15. PubMed ID: 22221053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.